These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25955122)

  • 1. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.
    Chakravarty R; Goel S; Hong H; Chen F; Valdovinos HF; Hernandez R; Barnhart TE; Cai W
    Nanomedicine (Lond); 2015; 10(8):1233-46. PubMed ID: 25955122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.
    She X; Chen L; Velleman L; Li C; Zhu H; He C; Wang T; Shigdar S; Duan W; Kong L
    J Colloid Interface Sci; 2015 May; 445():151-160. PubMed ID: 25617610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy.
    Liu J; Luo Z; Zhang J; Luo T; Zhou J; Zhao X; Cai K
    Biomaterials; 2016 Mar; 83():51-65. PubMed ID: 26773665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
    Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y
    Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shape-Controlled Hollow Mesoporous Silica Nanoparticles with Multifunctional Capping for In Vitro Cancer Treatment.
    Geng H; Chen W; Xu ZP; Qian G; An J; Zhang H
    Chemistry; 2017 Aug; 23(45):10878-10885. PubMed ID: 28580592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
    Li X; Wu M; Pan L; Shi J
    Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial Bioparameters.
    Bao X; Wang MW; Luo JM; Wang SY; Zhang YP; Zhang YJ
    Theranostics; 2016; 6(12):2084-2098. PubMed ID: 27698942
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
    Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
    Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
    Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
    Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles.
    Chen F; Hong H; Zhang Y; Valdovinos HF; Shi S; Kwon GS; Theuer CP; Barnhart TE; Cai W
    ACS Nano; 2013 Oct; 7(10):9027-39. PubMed ID: 24083623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.
    Chen L; She X; Wang T; He L; Shigdar S; Duan W; Kong L
    Nanoscale; 2015 Sep; 7(33):14080-92. PubMed ID: 26242620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging.
    Yang X; Hong H; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Xiao Y; Yang Y; Zhang Y; Nickles RJ; Cai W; Steeber DA; Gong S
    Biomaterials; 2011 Jun; 32(17):4151-60. PubMed ID: 21367450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchically mesoporous silica nanoparticles: extraction, amino-functionalization, and their multipurpose potentials.
    Du X; He J
    Langmuir; 2011 Mar; 27(6):2972-9. PubMed ID: 21332153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system.
    Goel S; Chen F; Hong H; Valdovinos HF; Hernandez R; Shi S; Barnhart TE; Cai W
    ACS Appl Mater Interfaces; 2014 Dec; 6(23):21677-85. PubMed ID: 25353068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells.
    Liu Y; Chen Q; Xu M; Guan G; Hu W; Liang Y; Zhao X; Qiao M; Chen D; Liu H
    Int J Nanomedicine; 2015; 10():1855-67. PubMed ID: 25834425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
    Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J
    J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordination-Accelerated "Iron Extraction" Enables Fast Biodegradation of Mesoporous Silica-Based Hollow Nanoparticles.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
    Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
    Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy.
    Ke Y; Xiang C
    Int J Nanomedicine; 2018; 13():8339-8354. PubMed ID: 30584304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles.
    Yu L; Chen Y; Wu M; Cai X; Yao H; Zhang L; Chen H; Shi J
    J Am Chem Soc; 2016 Aug; 138(31):9881-94. PubMed ID: 27441571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.